Cargando…
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751801/ https://www.ncbi.nlm.nih.gov/pubmed/35028526 http://dx.doi.org/10.1097/HS9.0000000000000672 |
| _version_ | 1784631753428697088 |
|---|---|
| author | Houot, Roch Poeschel, Viola Altmann, Bettina Angel, Stephanie Thurner, Lorenz Illmer, Thomas Andre, Marc Dreyling, Martin Maisonneuve, Hervé Tilly, Hervé Mayer, Stephanie Casasnovas, Olivier Le Gouill, Steven Offner, Fritz Cartron, Guillaume Kerkhoff, Andrea Weber, Thomas Hoffmann, Joerg Ziepert, Marita Klapper, Wolfram Itti, Emmanuel Hellwig, Dirk Natchkebia, Giorgi de Leval, Laurence Rosenwald, Andreas Haioun, Corinne Dercle, Laurent Gaulard, Philippe Held, Gerhard |
| author_facet | Houot, Roch Poeschel, Viola Altmann, Bettina Angel, Stephanie Thurner, Lorenz Illmer, Thomas Andre, Marc Dreyling, Martin Maisonneuve, Hervé Tilly, Hervé Mayer, Stephanie Casasnovas, Olivier Le Gouill, Steven Offner, Fritz Cartron, Guillaume Kerkhoff, Andrea Weber, Thomas Hoffmann, Joerg Ziepert, Marita Klapper, Wolfram Itti, Emmanuel Hellwig, Dirk Natchkebia, Giorgi de Leval, Laurence Rosenwald, Andreas Haioun, Corinne Dercle, Laurent Gaulard, Philippe Held, Gerhard |
| author_sort | Houot, Roch |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8751801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87518012022-01-12 Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma Houot, Roch Poeschel, Viola Altmann, Bettina Angel, Stephanie Thurner, Lorenz Illmer, Thomas Andre, Marc Dreyling, Martin Maisonneuve, Hervé Tilly, Hervé Mayer, Stephanie Casasnovas, Olivier Le Gouill, Steven Offner, Fritz Cartron, Guillaume Kerkhoff, Andrea Weber, Thomas Hoffmann, Joerg Ziepert, Marita Klapper, Wolfram Itti, Emmanuel Hellwig, Dirk Natchkebia, Giorgi de Leval, Laurence Rosenwald, Andreas Haioun, Corinne Dercle, Laurent Gaulard, Philippe Held, Gerhard Hemasphere Letter Lippincott Williams & Wilkins 2022-01-10 /pmc/articles/PMC8751801/ /pubmed/35028526 http://dx.doi.org/10.1097/HS9.0000000000000672 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Houot, Roch Poeschel, Viola Altmann, Bettina Angel, Stephanie Thurner, Lorenz Illmer, Thomas Andre, Marc Dreyling, Martin Maisonneuve, Hervé Tilly, Hervé Mayer, Stephanie Casasnovas, Olivier Le Gouill, Steven Offner, Fritz Cartron, Guillaume Kerkhoff, Andrea Weber, Thomas Hoffmann, Joerg Ziepert, Marita Klapper, Wolfram Itti, Emmanuel Hellwig, Dirk Natchkebia, Giorgi de Leval, Laurence Rosenwald, Andreas Haioun, Corinne Dercle, Laurent Gaulard, Philippe Held, Gerhard Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma |
| title | Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma |
| title_full | Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma |
| title_fullStr | Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma |
| title_full_unstemmed | Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma |
| title_short | Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma |
| title_sort | prolonged remissions after nivolumab plus gemcitabine/oxaliplatin in relapsed/refractory t-cell lymphoma |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751801/ https://www.ncbi.nlm.nih.gov/pubmed/35028526 http://dx.doi.org/10.1097/HS9.0000000000000672 |
| work_keys_str_mv | AT houotroch prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT poeschelviola prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT altmannbettina prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT angelstephanie prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT thurnerlorenz prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT illmerthomas prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT andremarc prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT dreylingmartin prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT maisonneuveherve prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT tillyherve prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT mayerstephanie prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT casasnovasolivier prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT legouillsteven prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT offnerfritz prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT cartronguillaume prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT kerkhoffandrea prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT weberthomas prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT hoffmannjoerg prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT ziepertmarita prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT klapperwolfram prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT ittiemmanuel prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT hellwigdirk prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT natchkebiagiorgi prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT delevallaurence prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT rosenwaldandreas prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT haiouncorinne prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT derclelaurent prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT gaulardphilippe prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma AT heldgerhard prolongedremissionsafternivolumabplusgemcitabineoxaliplatininrelapsedrefractorytcelllymphoma |